Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe site footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now renders a 403 Forbidden error page with the site header and footer visible, indicating the study record is temporarily inaccessible.SummaryDifference17%

- Check66 days agoChange DetectedRevision history now shows v3.6.6 in place of v3.6.5, indicating a software patch release. The change records an update to the underlying system version, not a modification of page content.SummaryDifference0.1%

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.